Newsroom

JUNE 29, 2017 Glytec Receives Five Additional Patent Allowances for its Diabetes Therapy Management Software Poised to address diabetes on a global scale, the company expands its intellectual property protections in the United States and abroad. WALTHAM, MA — Glytec, the healthcare company behind a market-leading software solution for personalized diabetes therapy management, announces five new...

JUNE 21, 2017

DECEMBER 15, 2016 Glytec Grows its Patent Portfolio with Another Notice of Allowance for its Precision Diabetes Management Technologies This latest notice of allowance from the United States Patent and Trademark Office deepens Glytec’s intellectual property protections and further validates its leadership stature in the healthcare market. Waltham, MA — Glytec today announces another notice of...

SEPTEMBER 27, 2016 Glytec Receives Three Additional Patent Notices of Allowance from USPTO for its Breakthrough Diabetes Technologies The notices further validate Glytec’s position as a leader in advanced technologies and innovations for glycemic management. Waltham, MA — Glytec today announces notices of allowance received from the United States Patent and Trademark Office (USPTO) for three...

MARCH 7, 2016 Putting Epic's EHR to Work: Hawaii Pacific Executives on the Intersection of Health IT & Quality We started on this journey because we identified patients with diabetes and their comorbidities as top reasons for readmissions and longer length of stay. Hawaii Pacific Health, based in Honolulu, is no stranger to the Epic EHR. The health system's contract with the EHR vendor is...

Second allowance covers its unique insulin administration method. Waltham, MA — Glytec, the pioneer and leader in providing innovative glucose management software solutions, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent application directed toward a method of administering insulin proven to improve patient outcomes compared to...

The allowed claims are directed to a system for glycemic control of a diabetic patient that includes a smartphone-based diabetes mobile application, which will provide patients with real-time insulin dosing guidance, leveraging Glytec’s proprietary insulin titration technology. Waltham, MA — Glytec, the pioneer and leader in providing innovative glucose management software solutions,...

May 2, 2012 Glytec Achieves ISO Certification Glytec is the first company to achieve this medical device certification in the glycemic management product space. Greenville, SC — Glytec, LLC, a privately held medical software company, announced that it has achieved the ISO 13485:2003 Certification for its quality management and assurance processes for the safe design, production and installation...

May 11, 2011 Glytec Earns U.S. Department of Commerce Safe Harbor Certification for European Union Glytec, a world leader in glycemic management solutions, has announced that it has achieved the U.S. Department of Commerce Safe Harbor Certification. Greenville, SC — The Safe Harbor provides a legal framework allowing for protection of personal data generated from European countries and the safe...

June 20, 2010 Glytec Announces FDA 510(k) Clearance on G+ Enterprise Edition Insulin Dosing Software Glytec announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its G+ System Enterprise Edition, the next generation of the industry standard sophisticated insulin management software system. Glytec, LLC, a wholly-owned subsidiary of GlucoTec, Inc.,...